People have read about it in the magazines, they've watched about it on the television news, and now Celrase has been approved for sale here in the United States. Meadow Creek Laboratories, announced today that they have received full clearance to begin immediate marketing and sales of their Celrase product to US consumers. Celrase has been generating national media attention since it was first reported that the product is effective at melting away cellulite.
Celrase is a non-invasive body contouring cellulite product that can melt stubborn areas of fat and tighten skin on the face, neck, arms, back, abdominal area, hips, thighs and knees. The ground-breaking technology employed by the product is a blend of its' proprietary active ingredients in a duo combination (Adiposlim and Adipoless) that acts on fat cells, thereby liquefying fat so that it can be easily drained or absorbed by the body's lymphatic system where it is flushed naturally from the body. An added benefit of Celrase is its skin tightening capability, which further enhances the results especially for 35+ men and women.
"Celrase represents the most advanced, non-invasive, cellulite reduction technology produced to date. Today's announcement is a unique moment in the beauty industry as it shows that slimming, anti-cellulite personal care products like Celrase are going to make a huge impact on the beauty market. We have already seen the positive reception that the product has garnered through the media and the response has been quite clear that Celrase is a product that works. We are bracing ourselves for this product to fly off the shelves" said Audrey Summers, Marketing Director North America.
Luxury scented professional grade Celrase is a one-step anti-cellulite product targeted at both men and women with slimming and cellulite goals. The fast working cream is applied to the problem areas of the body where it begins to quickly penetrate. Celrase absorbs quickly so clothing can be put on shortly after applying.
More complete detailed product information and directions of use can be found on www.Celrase.com
) May 4, 2007